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Abstract
The kidney has a high energy demand and is dependent on oxidative metabolism for ATP
production. Accordingly, the kidney is rich in mitochondria, and mitochondrial dysfunction is
a common denominator for several renal diseases. While the mitochondrial master regula-
tor peroxisome proliferator-activated receptor γ coactivator 1α (PGC-1α) is highly
expressed in kidney, its role in renal physiology is so far unclear. Here we show that PGC-
1α is a transcriptional regulator of mitochondrial metabolic pathways in the kidney. More-
over, we demonstrate that mice with an inducible nephron-specific inactivation of PGC-1α
in the kidney display elevated urinary sodium excretion, exacerbated renal steatosis during
metabolic stress but normal blood pressure regulation. Overall, PGC-1α seems largely dis-
pensable for basal renal physiology. However, the role of PGC-1α in renal mitochondrial
biogenesis indicates that activation of PGC-1α in the context of renal disorders could be a
valid therapeutic strategy to ameliorate renal mitochondrial dysfunction.
Introduction
The kidney is an important organ for the clearance of metabolic waste products from the blood,
for maintaining body salt and fluid balance and for blood pressure homeostasis. This is achieved
through passive filtration of plasma in the glomerulus, which is coupled to a system of transport-
ers along the nephron, responsible for maintaining systemic nutrient- and salt homeostasis [1].
Tubular reabsorption is an energy-demanding process and the majority of ATP (~95%) in the
kidney is produced through oxidative metabolism [2,3]. Consequently, mitochondrial density is
highest in tubule segments associated with high basal transcellular transport rates, such as the
proximal tubules and the thick loop of Henle [3]. The integral role of mitochondrial metabolism
in renal function is underscored by the prevalence of renal dysfunction in patients suffering from
mitochondrial cytopathies [2,4,5]. The peroxisome proliferator-activated receptor γ coactivator
1α (PGC-1α) is an important regulator of mitochondrial function [6]. While PGC-1α is highly
expressed in the kidneys [7], the role of PGC-1α in renal physiology is so far unclear. To address
this gap in knowledge, we have generated and characterized mice with a nephron-specific induc-
ible PGC-1α knockout (NiPKO). Inactivation of PGC-1α in the kidney resulted in reduced
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expression of mitochondrial enzymes. NiPKOmice displayed a mild sodium-losing phenotype,
but otherwise showed normal regulation of salt and water balance and blood pressure. Impor-
tantly, we found that PGC-1α is necessary for the transcriptional induction of lipid metabolic
processes in the kidney upon high fat diet feeding. Consequently, NiPKOmice develop renal
hypertriglyceridemia in this dietary context. Collectively, our results indicate a minor role for
PGC-1α in basal renal physiology, mainly affecting age-related sodium excretion. Moreover, we
observed a central role for PGC-1α in the transcriptional regulation of mitochondrial and meta-
bolic processes in the kidney, most notably during high-fat diet feeding, with consequences on
lipid accumulation and inflammation.
Materials and Methods
Animals and diets
Animals were housed in a conventional facility with a 12-h light/12-h dark cycle with free
access to food and water. Mice were sacrificed by CO2 inhalation or terminal bleeding of anaes-
thetized animals. All experiments were performed in accordance with federal guidelines and
were approved by the Kantonales Veterinäramt of Kanton Basel-Stadt under the consideration
of 3R and to ensure minimal pain and stress in the animals. To generate nephron-specific
inducible PGC-1α knockout (NiPKO) mice, we crossed mice with transgenic expression of the
reverse tetracycline-dependent transactivator (rtTA) under control of the Pax8-promoter
(Pax8-rtTA, a kind gift from Dr. Robert Koesters) [8] with transgenic (tetO-cre)-LC1 mice
(obtained from the European Mouse Mutant Archive) [9]. These double-transgenic mice were
subsequently crossed with mice having two floxed PGC-1α alleles (PGC-1αfl/fl, from internal
breeding) [10]. While the PGC-1αfl/fl mice are in a C57BL/6 strain background, the LC1 and
the Pax8-rtTA were in a mixed background. To account for that, littermate controls were used
in all experiments. All experiments were performed in male mice. To induce the knockout of
PGC-1α, doxycycline (DOX) (Sigma) (0.2 mg/mL) was administered ad libitum to the drinking
water of 12 week old mice, with the addition of 2% sucrose (Sigma) to enhance palatability.
After two weeks, mice were switched back to regular drinking water and were allowed at least
one week of rest before experiments started. Recombination PCR was performed using primers
binding to a region surrounding exons 3–5 of PGC-1α; forward 5’-TCCAGTAGGCAGAGA
TTTATGAC-3’, reverse 5’- CCAACTGTCTATAATTCCAGTTC-3’. This primer pair yields a
product when exons 3–5 of PGC-1α are excised [10]. A control PCR reaction was performed
using the following primers; forward 5’- ACCTGTCTTTGCCTATGATTC-3’, reverse 5’-CCA
GTTTCTTCATTGGTGTG-3’. The experimental diets used for this study were either obtained
from Harlan Teklad (low sodium diet (LSD,<0.02% Na) (TD.90228)) or from Research Diets
Inc (high fat diet (HFD, 60 kcal% fat, D12492)). Blood pressure was measured in restrained
conscious mice using a non-invasive tail-cuff blood pressure analyzer (BP-2000, Visitech sys-
tem, Bioseb). The mice were acclimatized to this method for 5 consecutive days, measurements
were taken for 5 days and values averaged similar to previous studies [11]. Body composition
was measured using an EchoMRI-100™ analyzer (EchoMRI Medical Systems).
Blood and urine analysis
For urine collection, mice were housed in single mouse metabolic cages (3600M021, Tecni-
plast) overnight (16 hours) or for 24 hours. Amount of food and water consumed was
recorded, and urine was collected for further analysis. For plasma analysis, whole tail-vein
blood was collected in Microvette tubes (Sarstedt). Levels of sodium, chloride, potassium, cal-
cium, protein, urea and creatinine (enzymatic method) levels in urine and plasma were deter-
mined using an automated biochemical analyzer (Cobas c111 analyzer; Roche).
PGC-1α Function in the Nephron
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RNA extraction and RT-PCR
Frozen tissue was homogenized using TRIzol reagent (Invitrogen) before addition of chloro-
phorm an centrifugation at 12’000 g for 15 min. Clear supernatant was removed and incubated
with isopropanol before centrifugation at 12’000 g for 10 min. Then, pellet was washed twice
with 75% ethanol and final pellet dissolved in water. RNA concentration was adjusted and
cDNA synthesis was performed using 1 μg of total RNA. Semi-quantitative real-time PCR anal-
ysis was performed using Fast SYBR Green master mix (Applied Biosystems) on a StepOnePlus
Real-Time PCR System (Applied Biosystems). Relative expression levels for each gene of inter-
est were calculated with the ΔΔCt method, normalizing against mRNA levels of eukaryotic
elongation factor 2 (eEF2) or TATA-binding protein (Tbp). A list of primer sequences used in
this study can be found in S1 Table.
Gene expression array
Gene expression analysis of control and NiPKO kidneys was performed using 4 samples per
group, with the Affymetrix GeneChip Mouse Gene 2.0 ST microarray. Transcripts were con-
sidered significantly altered if having a p-values<0.05 and a fold-change of>1.2. Pathway
enrichment analysis was performed using Babelomics [12] and the Kyoto Encyclopedia of
Genes and Genomes (KEGG) database [13]. KEGG terms were considered significantly
enriched with a cut-off of p-values<0.05. Integrated System for Motif Activity Response Analy-
sis (ISMARA) [14] was used to predict the core transcription factors driving the transcriptional
changes observed in our gene expression array.
Mitochondrial DNA (mtDNA) analysis
Analysis of mtDNA was performed similar to previous descriptions [15]. Frozen tissue was
homogenized and DNA was extracted via a standard phenol/chloroform extraction protocol.
DNA concentration was adjusted and the relative amount of mtDNA (primers against mtDNA
D-loop region) to nuclear DNA (Ndufv1 primers) was analyzed using Fast SYBR Green master
mix (Applied Biosystems) on a StepOnePlus Real-Time PCR System (Applied Biosystems).
Protein isolation and immunoblotting
Frozen tissues were homogenized in radioimmunoprecipitation assay (RIPA) buffer and after
centrifugation at 13’000 g protein concentration of the supernatant was measured using the
Bradford method (Biorad). Equal amounts of proteins were separated on SDS-PAGE under
reducing conditions and transferred to a nitrocellulose membrane (Whatman). Proteins of
interest were detected using the following primary antibodies: Mitoprofile (MS604, MitoS-
ciences), NKCC2 (sc-133823, Santa Cruz Biotechnology), NCCT (sc-21554, Santa Cruz Bio-
technology) and eEF2 (2332; Cell signaling). Densitometric analysis of immunoblots was
performed on 6 individual samples using Image-J software and a representative selection from
this group is presented in each figure.
Histology
After extraction, kidneys were fixed in 4% paraformaldehyde/PBS at 4°C overnight. Kidneys
were subsequently dehydrated, embedded in paraffin and 5 μm thick sections were cut using a
microtome. For general histology, a Periodic Acid-Schiff (PAS) staining was performed accord-
ing to the manufacturer’s instructions (PAS Kit, Sigma).
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Isolation of triglycerides from kidney
Triglycerides were isolated from snap-frozen kidney as previously described (Svensson et al.,
2015). Briefly, frozen kidney tissue was homogenized in a 2:1 chloroform/methanol mixture.
The organic phase was subsequently dried under N2, re-suspended and cleaned on a solid
phase extraction column. Triglycerides were measured using a commercial enzymatic kit (TG
PAP 150, BioMérieux) and normalized to the initial weight of the tissue used for extraction.
Statistical analysis
All data are presented as means ± SEM. Unpaired student two-tailed t-test was used to deter-
mine differences between groups.
Results
Knockout of PGC-1α in renal tubular cells results in a mild salt-losing
phenotype
To inactivate PGC-1α in the kidney, we generated nephron-specific inducible PGC-1α knock-
out (NiPKO) mice by crossing transgenic Pax8rtTA-(tetO-cre)-LC1 animals [8,9] with mice
harboring floxed PGC-1α alleles (PGC-1αfl/fl) [10] (Fig 1A). Through administration of doxy-
cycline (DOX), this system allows specific inactivation of PGC-1α in the complete renal tubule
Fig 1. Kidney-specific inactivation of PGC-1α in NiPKOmice. (A) Nephron-specific inducible PGC-1α knockout (NiPKO) mice were generated by
crossing transgenic Pax8rtTA-(tetO-cre)-LC1 mice with mice having two floxed PGC-1α alleles (PGC-1αfl/fl). Knockout was induced through doxycycline
administration for 14 days. (B) Representative recombination PCR for PGC- 1α on DNA extracted from kidney, heart, liver, epididymal white adipose tissue
(eWAT) and skeletal muscle. The amplified products for the wild-type and knockout alleles are approximately 650 bp and 420 bp, respectively. (C) mRNA
levels of PGC-1α in kidney, heart, liver, eWAT and skeletal muscle, normalized to eukaryotic elongation factor 2 (eEF2) mRNA levels (n = 5–7). (D) mRNA
levels of indicated genes in kidney normalized to eEF2 mRNA levels (n = 7–8). (E) Body weight and (F) average kidney weight normalized to body weight of
mice at 1 and 12 months after doxycycline administration (n = 6–16). (G) Representative pictures of kidney histology at 1 and 12 months after doxycycline
administration (n = 3). Error bars represent mean ±SEM. Significant differences (p-value <0.05) between genotypes are indicated by an asterisk (*).
doi:10.1371/journal.pone.0158716.g001
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system while sparing the glomerulus [8]. Successful recombination of exon 3–5 of PGC-1α was
confirmed in kidney from NiPKO mice after DOX-administration (Fig 1B). In line with a low
Pax8 expression in liver [8], we also detected recombination of PGC-1α in liver of NiPKO
mice (Fig 1B). However, while PGC-1αmRNA expression was strongly diminished in the kid-
ney, there was no significant reduction in PGC-1α transcript levels in the liver (Fig 1C). All
other tissues tested showed unchanged PGC-1αmRNA levels between control and NiPKO
mice (Fig 1C). The inactivation of PGC-1α in kidney did not affect expression of the related
family members PGC-1β and PGC1-related coactivator (PRC) (Fig 1D), but resulted in signifi-
cantly reduced transcript levels of known PGC-1α target genes such as estrogen related recep-
tor α (ERRα) and citrate synthase (Cs) (Fig 1D). Next, the phenotype of the NiPKO mice was
investigated in young mice (1 month after DOX administration) and aged mice (12 months
after DOX administration). Inactivation of PGC-1α in kidney led to no significant changes in
either body weight (Fig 1E) or relative kidney weight (Fig 1F) in either age category. Moreover,
kidneys from NiPKO mice displayed normal histological features compared to control mice
(Fig 1G, S1A and S1B Fig). Subsequently, we analyzed salt and water homeostasis and blood
pressure in control and NiPKO mice. Inactivation of PGC- 1α in the kidney did not affect
water intake or urine output in either young (Fig 2A) or aged (Fig 2B) NiPKO mice compared
to control mice. Similarly, systolic and diastolic blood pressure was indistinguishable between
the groups at these time points (Fig 2C and 2D). Interestingly, NiPKO mice displayed a signifi-
cant increase in urinary sodium excretion when normalized to urinary creatinine excretion in
both young (Fig 2E) and aged animals (Fig 2F). However, there was no significant difference
for the urinary excretion of chloride, potassium and calcium or for proteins and urea (Fig 2E
and 2F), or in plasma levels of sodium or any of the above-mentioned parameters (S2A and
S2B Fig). The increased urinary sodium excretion was not connected to alterations in transcript
levels of the epithelial Na+ channel α (ENaCα), ENaCβ or ENaCγ subunits in either young or
aged mice (Fig 2G and 2H). Likewise, no differences in transcript (Fig 2G and 2H) or protein
(Fig 2I and 2J) levels of the Na+-Cl− cotransporter (NCCT) or Na+-K+-Cl− cotransporter
(NKCC2) were detected. These data indicate that NiPKO mice display a largely normal regula-
tion of water intake, urine output and blood pressure, but display a mild sodium-losing pheno-
type in the basal state.
Aged NiPKOmice cannot adapt their sodium excretion during low salt
diet feeding
The small elevation in urinary sodium excretion in NiPKO mice indicates a role for PGC-1α in
the maintenance of renal salt homeostasis. To test this notion, we exposed control and NiPKO
animals to a dietary salt stress and assessed salt- and water homeostasis. Control and NiPKO
mice were administered a standardized diet containing<0.02% NaCl (low salt diet, LSD) for 5
consecutive weeks, starting at either 1 or 12 months after DOX-administration. LSD-feeding
did not affect body weight in either group (Fig 3A) and there was no significant difference in
food intake (Fig 3B) or water intake (Fig 3C) between LSD-fed control and NiPKO mice. Inter-
estingly, despite the mild salt-losing phenotype in the basal state (Fig 2E), young NiPKOmice
could adapt their urinary sodium excretion to the same extent as control mice during LSD
feeding (Fig 3D). Consequently, there were no differences in either urine output (Fig 3E) or
urine-to-water ratio (Fig 3F) between young control and NiPKO mice with LSD feeding. In
contrast to the young mice however, aged NiPKO mice displayed elevated urinary sodium lev-
els (Fig 3D) with a concomitant elevated urine output (Fig 3E) and urine-to-water ratio (Fig
3F) in aged NiPKO mice compared to control mice with LSD feeding. Collectively, these data
indicate that while young NiPKO mice can adapt their reabsorption of urinary sodium during
PGC-1α Function in the Nephron
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a reduced dietary salt intake to the same extent as control mice, this process is impaired in aged
NiPKOmice. Similar to chow-fed mice (Fig 2G and 2H), there were no differences in transcript
levels of the sodium transporters ENaC (α/β/γ subunits), NCCT or NKCC2 between young or
aged control and NiPKO mice (Fig 3G and 3H). Interestingly, while protein levels of NCCT
and NKCC2 were comparable between young LSD-fed control and NiPKO mice (Fig 3I), aged
NiPKO mice displayed significantly reduced renal protein levels of both NCCT and NKCC2
compared to control mice while the phosphorylated forms of NCCT and NKCC2 were not
Fig 2. NiPKOmice display elevated sodium-excretion in urine. (A-B) Water intake and urine output in mice over 24 hours, at (A) 1 month and
(B) 12 months after doxycycline administration (n = 8–13). (C-D) Systolic and diastolic blood pressure measured via tail-cuff
photoplethysmography at (C) 1 month and (D) 12 months after doxycycline administration (n = 6–8). (E-F) Urinary levels of calcium (Ca2+),
chloride (Cl-), potassium (K+), sodium (Na+), protein and urea over 24 hours, normalized to urinary excretion of creatinine, at (E) 1 month and (F)
12 months after doxycycline administration (n = 8–13). (G-H) mRNA levels of indicated genes in kidney normalized to TbpmRNA levels, at (G) 1
month and (H) 12 months after doxycycline administration (n = 6). (I-J) Representative immunoblots of NCCT, NKCC2 and eEF2 in kidney. Bar
graph shows quantification of band intensities of NCCT and NKCC2 relative to eEF2 (n = 6). Error bars represent mean ±SEM. Significant
differences (p-value<0.05) between genotypes are indicated by an asterisk (*).
doi:10.1371/journal.pone.0158716.g002
PGC-1α Function in the Nephron
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different between the groups at either age (Fig 3I and 3J). Importantly, the reduced levels of the
renal sodium-transporters NCCT and NKCC2 in aged NiPKO mice could explain the salt
Fig 3. Aged NiPKOmice cannot adapt their salt- and water homeostasis to a reduced dietary salt intake.Control (CTRL) and NiPKOmice
were fed a standardized diet containing <0.02% NaCl (low salt diet, LSD) for 5 weeks, starting at either 1 month or 12 months after doxycycline
administration. (A) Body weight at end of LSD feeding period expressed as percentage of initial body weight (n = 6–8). (B) Food intake over 24
hours (n = 6–8). (C) Water intake over 24 hours (n = 6–8). (D) Urinary sodium (Na+) excretion normalized to urinary creatinine excretion (n = 6–8).
(E) Urine output over 24 hours (n = 6–8). (F) Urine-to-water ratio over 24 hours (n = 6–8). (G-H) mRNA levels of indicated genes in kidney
normalized to TbpmRNA levels, at (G) 1 month and (H) 12 months after DOX administration (n = 6). (I-J) Representative immunoblots of NCCT, p-
NCCT (Thr45/50/55), NKCC2, p-NKCC2 (Thr105) and eEF2 in kidney. Bar graph shows quantification of band intensities of total NCCT and
NKCC2 relative to eEF2 (n = 6). Error bars represent mean ±SEM. Significant differences (p-value <0.05) between genotypes are indicated by an
asterisk (*).
doi:10.1371/journal.pone.0158716.g003
PGC-1α Function in the Nephron
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losing phenotype specifically in this group. However, since transcription of the genes encoding
these channels was unaltered (Fig 3G and 3H), the reduced protein levels of NCCT and
NKCC2 is most likely an indirect effect of PGC-1α inactivation in aged mice.
PGC-1α regulates mitochondrial gene transcription in the kidney
PGC-1α is an important transcriptional regulator of mitochondrial and metabolic processes
[6]. Consequently, we were interested in how inactivation of PGC-1α affects the renal tran-
scriptome in mice fed a chow diet and in the context of high fat diet (HFD)-induced metabolic
stress. Accordingly, starting one week after the end of the DOX administration, control and
NiPKO mice were fed either a chow diet or a HFD (60 kcal% fat) for five months. At the end of
this period, HFD-fed control and NiPKO mice were significantly heavier than the chow fed
cohorts (Fig 4A). HFD-fed control and NiPKO mice gained a similar amount of weight and
displayed no difference in body composition (Fig 4A and 4B). Moreover, systolic and diastolic
blood pressure was unaltered between genotypes during HFD-feeding (Fig 4C). Similar to
chow fed mice (Fig 2E and 2F), we could confirm the salt-losing phenotype in HFD-fed
Fig 4. High fat diet-induced changes in control and NiPKOmice.Control (CTRL) and NiPKOmice were fed either a chow-diet (CHOW, 10 kcal
% fat) or a high fat diet (HFD, 60 kcal% fat) for 5 months, starting at 2 weeks after DOX-administration. (A) Body weight at the end of chow or HFD
feeding period (n = 10–15). (B) Body composition expressed as percentage lean and fat mass of total body weight of HFD-fed mice (n = 16). (C)
Systolic and diastolic blood pressure measured via tail- cuff photoplethysmography of HFD-fed mice (n = 10). (D) Urinary levels of calcium (Ca2+),
chloride (Cl-), potassium (K+), sodium (Na+), protein and urea over 16 hours, normalized to urinary excretion of creatinine, at the end of HFD
feeding period (n = 9). (E) Water intake and urine output over 16 hours of HFD-fed mice (n = 15–16). Error bars represent mean ±SEM. Significant
differences (p-value <0.05) between genotypes are indicated by an asterisk (*) and between chow- and HFD-fed groups by a number sign (#).
doi:10.1371/journal.pone.0158716.g004
PGC-1α Function in the Nephron
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NiPKO mice (Fig 4D). Interestingly, HFD- fed NiPKO mice displayed enhanced urinary excre-
tion not only of sodium, but also of chloride and calcium (Fig 4D). Despite the elevated levels
of electrolytes in the urine, HFD-fed NiPKO mice displayed unaltered water intake and urine
output compared to control mice (Fig 4E). Moreover, differences in food intake cannot account
for the modulation of chloride and calcium (S3 Fig). Overall, HFD-feeding exacerbated the loss
of ions in the urine, but did not significantly impact the overall ability of NiPKO mice to adjust
their salt and water homeostasis and blood pressure regulation. Accordingly, the transcrip-
tional regulation of several transporters by genotype or diet remains relatively mild (S4 Fig).
Next, we focused on changes in the renal transcriptome by performing a gene expression
array on kidney from chow- and HFD-fed control and NiPKO mice. A total of 1013 unique
genes (502 down, 511 up) were significantly changed in kidneys from chow-fed NiPKO mice
compared to chow-fed control mice. For HFD- fed NiPKO mice compared to HFD-fed control
mice, 825 genes (409 down, 416 up) were significantly changed (Fig 5A, S2 and S3 Tables). In
control mice, 1065 unique genes (545 down, 520 up) were significantly altered with HFD-feed-
ing while in NiPKO mice, the same comparison yielded 1041 significantly changed genes (505
down, 536 up) (Fig 5A, S2 and S3 Tables). To elucidate the functional networks regulated by
PGC-1α in kidney, we performed pathway enrichment analysis on differentially regulated tran-
scripts in NiPKO compared to control mice, using the Kyoto Encyclopedia of Genes and
Genomes (KEGG) database [13]. Terms associated with metabolic and mitochondrial pro-
cesses, including oxidative phosphorylation (mmu00190), the citrate cycle (mmu00020) and gly-
colysis (mmu00010) were significantly enriched amongst the downregulated genes in NiPKO
mice both in the chow-fed and HFD-fed cohorts (Fig 5B and 5C, S4 Table). Additionally, the
KEGG pathway enrichment analysis revealed terms such as Parkinson’s disease (mmu05012),
Huntington disease (mmu05016) and Alzheimer’s disease (mmu05010), which contain many
genes encoding mitochondrial proteins (e.g. cytochrome oxidase 7a1/Cox7a1, ATP-synthase
subunit 5h/Atp5h and cytochrome c/Cycs) to be downregulated in NiPKOs (Fig 5B and 5C, S4
Table). Hence, inactivation of PGC-1α in kidney leads to a robust reduction in the transcrip-
tion of genes associated with mitochondrial function and metabolism. In particular, in the
KEGG-category oxidative phosphorylation (mmu00190), many genes encoding proteins of the
mitochondrial electron transport chain were down- regulated in both chow- and HFD-fed
NiPKOmice compared to control mice (Fig 5D). We could furthermore validate the down-reg-
ulation of some selected mitochondrial oxidative phosphorylation components by RT-PCR
(Fig 6A). Thus, in analogy to other tissues (Villena, 2015), PGC-1α is an important transcrip-
tional regulator of mitochondrial genes also in the kidney. To investigate whether inactivation
of PGC-1α affects mitochondrial biogenesis in the kidney, we then assessed mitochondrial
DNA (mtDNA) content and mitochondrial protein expression in chow- and HFD-fed NiPKO
and control mice, respectively. HFD-feeding reduced relative mtDNA content in the kidney,
but there was no difference between genotypes (Fig 6B). On the other hand, there was a robust
reduction in protein levels of ATP5A and UQCRC2 in the kidney of chow-fed (Fig 6C), HFD-
fed (Fig 6D) and aged chow-fed (Fig 6E) NiPKO mice compared to control mice. In chow-fed
and aged chow-fed mice, COX1 levels were also significantly reduced in NiPKO compared to
control mice (Fig 6C and 6E), while NADH:ubiquinone oxidoreductase subunit B8 (NDUFB8)
protein levels were specifically reduced in kidneys from HFD-fed NiPKO mice (Fig 6D). Other
mitochondrial proteins tested were not significantly altered between control and NiPKO mice
(Fig 6C–6E). Taken together, PGC-1α is important for the transcriptional regulation of meta-
bolic and mitochondrial gene programs in the kidney. This leads to a reduction in protein lev-
els of some, but not all mitochondrial oxidative phosphorylation components, and does not
affect mitochondrial content in kidney, at least based on mtDNA levels.
PGC-1α Function in the Nephron
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Fig 5. PGC-1α regulates transcription of mitochondrial andmetabolic genes in kidney. (A) VENN diagrams displaying the number of
unique or overlapping down- or up-regulated genes (p<0.05 and fold change >1.2 cut-off) in either chow- or HFD-fed control (CTRL) or NiPKO
mice. (B-C) Top significant terms for KEGG pathway enrichment analysis of down- or up-regulated genes in kidneys from (B) chow- fed NiPKO
mice compared to CTRL mice or in (C) HFD-fed NiPKOmice compared to CTRL mice. (D) Heat map generated using probe set intensities for
transcripts associated with the KEGG-category “Oxidative phosphorylation” in Fig B and C, for CHOW and HFD-fed CTRL and NiPKOmice. Row
minimum = -3, row maximum = 3 fold change.
doi:10.1371/journal.pone.0158716.g005
PGC-1α Function in the Nephron
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Fig 6. NiPKOmice display reduced levels of mitochondrial enzymes in kidney. (A) mRNA levels of indicated genes in kidney normalized to
eEF2mRNA levels, in either CHOW- or HFD- fed control (CTRL) or NiPKOmice (n = 7–8). (B) Mitochondrial DNA (mtDNA) content expressed as
the relative content of mtDNA D-loop compared to the nuclearNdufv1 gene (n = 7). (C-E) Representative immunoblots of ATP5A, COX1, UQCRC2,
SDHB, NDUFB8 and eEF2 in kidney. Bar graph shows quantification of band intensities relative to eEF2 for either (C) chow-fed, (D) HFD-fed or (E)
aged chow- fed CTRL and NiPKOmice (n = 6). CI, CII, CIII, CIV and CV represents subunits of electron transport chain complex I, II, III, IV and V,
PGC-1α Function in the Nephron
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PGC-1α is important for adaptation of renal lipid metabolism with HFD
feeding
To further elucidate the PGC-1α-regulated transcriptional network in kidney, we used Inte-
grated Motif Activity Response Analysis (ISMARA) [14] to assess the core set of transcription
factors (TF) that display altered activity with inactivation of PGC-1α. Interestingly, ERRα
(ESRRA.p2) was amongst the top-scoring TF motifs with reduced activity in both chow-fed
(S5A Fig) and HFD-fed (S5B Fig) NiPKO mice. ERRα is a well- known partner of PGC-1α in
the regulation of mitochondrial gene transcription [16], and impaired ERRα activity in both
chow-fed and HFD-fed NiPKO animals (S5C Fig) likely contributes to the reduction in mito-
chondrial gene transcription in the kidney of these mice. Additionally, in chow-fed NiPKO
mice, the recently described transcriptional partner of PGC-1α/ERRα, Krüppel-like factor 4
(KLF4) [17], was predicted to have reduced activity (S5A Fig). Inversely, nuclear factor κB
(NF-κB) activity (NFKB1_REL_RELA.p2) was predicted to be specifically increased in HFD-
fed (S5E Fig) but not in the chow-fed (S5D Fig) NiPKO mice compared to control animals.
NF-κB is a central transcriptional regulator of the inflammatory gene program, which is upre-
gulated in kidney during high fat diet feeding (Stemmer et al., 2012). Furthermore, in skeletal
muscle cells, the transcriptional activity of NF-κB and pro- inflammatory gene expression is
reduced by PGC-1α [18]. Accordingly, when comparing chow-fed to HFD-fed groups, NF-κB
activity was predicted to be increased with HFD feeding in NiPKOmice, but not in control
mice (S3C and S3D Fig). Thus, NF-κB activity seems to be induced in NiPKO mice upon
HFD-feeding to a higher extent than in control mice (S3F Fig), which could indicate that there
is a difference in the inflammatory response to HFD feeding between control and NiPKO mice.
Next, we analyzed the transcriptional networks affected by HFD feeding in the kidney of
both genotypes via KEGG pathway enrichment analysis to investigate whether NiPKO mice
display any alterations in their adaptation to a HFD compared to control mice. In regard to
transcripts significantly down-regulated by HFD feeding, the term steroid biosynthesis
(mmu00100) was significantly enriched in both NiPKO and control mice (Fig 7A and 7B, S5
Table). This indicates that this process is downregulated by HFD feeding in the kidney, but not
further affected by the absence of PGC-1α. However, in line with the predicted increase in NF-
κB activity, HFD-fed NiPKOmice displayed several KEGG terms enriched amongst their upre-
gulated genes that were associated with inflammation and immune response, such as primary
immunodeficiencies (mmu05340), the JAK/STAT pathway (mmu04630) and Toll-like receptor
signaling pathway (mmu04620) (Fig 7B, S5 Table). Importantly, none of these terms were
found associated with the upregulated transcripts in HFD-fed control mice (Fig 7A, S5 Table).
Contrariwise, the two most significant KEGG terms for the upregulated genes in HFD-fed con-
trol mice, PPAR signaling pathway (mmu03320) and fatty acid degradation (mmu00071) (Fig
7A), were not enriched amongst the up- regulated processes in NiPKO mice (Fig 7B). Within
the KEGG-categories PPAR signaling pathway and fatty acid degradation, we found several
genes associated with lipid metabolism that were induced by HFD feeding in control mice, but
not in NiPKO mice (e.g. acetyl-CoA acyltransferase 2/Acaa2, apolipoprotein A2/Apoa2, fatty
acid binding protein 1/Fabp1) (Fig 7C). Collectively, this indicates that induction of lipid meta-
bolic processes with HFD-feeding in kidney is dependent on PGC-1α. Since one of the main
upregulated terms in HFD-fed control mice was PPAR signaling pathway, we measured tran-
script levels of the peroxisome proliferator-activated receptors (PPAR) in kidney of control
respectively. Error bars represent mean ±SEM. Significant differences (p-value <0.05) between genotypes are indicated by an asterisk (*) and
between chow- and HFD-fed groups by a number sign (#).
doi:10.1371/journal.pone.0158716.g006
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Fig 7. NiPKOmice develop exacerbated renal steatosis with high fat diet-feeding. KEGG pathway enrichment analysis performed on gene
expression array data from kidney from either CHOW or HFD-fed control (CTRL) or NiPKOmice. (A-B) Top significant terms for KEGG pathway
enrichment analysis of transcripts either down- or up-regulated with HFD-feeding in (A) CTRL or (B) NiPKOmice. (C) Heat map generated using
probe set intensities for transcripts associated with the KEGG-categories “PPAR signaling pathway” and “Fatty acid degradation” in figure A, for
CHOW- and HFD-fed CTRL or NiPKOmice. Rowminimum = -10, row maximum = 10 fold change. (D-E) mRNA levels of indicated genes in kidney
normalized to eEF2 mRNA levels, in CHOW or HFD-fed CTRL or NiPKOmice (n = 7–8). (F) Triglycerides in kidney from CHOW- and HFD-fed
CTRL or NiPKOmice (n = 6–8). Error bars represent mean ±SEM. Significant differences (p-value <0.05) between genotypes are indicated by an
asterisk (*) and between chow- and HFD-fed groups by a number sign (#).
doi:10.1371/journal.pone.0158716.g007
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and NiPKO mice. Interestingly, while neither PPARβ/δ nor PPARγ were induced, PPARα
transcript levels were increased in the kidney of HFD-fed mice (Fig 7D) and this induction of
PPARα was blunted in HFD- fed NiPKO mice (Fig 7D). Accordingly, a similar transcriptional
pattern could be observed for several PPARα target genes involved in fatty acid metabolism
(Fig 7E), since HFD feeding led to an increased transcription of acyl-CoA thioesterase 2
(Acot2), Acot3, solute carrier family 25 (carnitine/acylcarnitine translocase) member 20
(Slc25a20), acyl-CoA dehydrogenase very long chain (Acadvl) and acyl-CoA dehydrogenase
long chain (Acadl) in kidneys of control mice, and this induction was again blunted in NiPKO
mice (Fig 7E). Importantly, triglyceride levels were significantly elevated in kidney of HFD-fed
NiPKO mice compared to control mice (Fig 7F) indicating that the reduced transcription of
fatty acid metabolism in kidney of NiPKO mice was indeed associated with alterations in renal
lipid handling. Thus, PGC-1α is important for the adaptation of renal lipid metabolism in
response to HFD feeding, and inactivation of PGC-1α in the kidney exacerbates renal hypertri-
glyceridemia and subsequent inflammation during HFD feeding.
Discussion
The kidney has a high energy demand and relies almost exclusively on oxidative phosphoryla-
tion for ATP production [2,3]. The importance of mitochondria for renal function is under-
scored by the prevalence of renal dysfunction in mitochondrial cytopathies [2,4,5].
Additionally, mitochondrial dysfunction is a hallmark sign of several renal disorders
[19,20,21,22]. PGC-1α is a key regulator of mitochondrial oxidative phosphorylation and oxi-
dative metabolism [6]. Surprisingly, despite the importance of mitochondrial energy metabo-
lism for renal function, relatively little is known about how PGC-1α influences renal function
and physiology. We now demonstrate that PGC-1α is an important transcriptional regulator
of mitochondrial gene programs in kidney, such as oxidative phosphorylation, TCA cycle and
fatty acid metabolism. However, despite the role of PGC-1α in transcriptional regulation of
mitochondrial genes, inactivation of PGC-1α in the kidney had only minor effects on the regu-
lation of blood pressure and salt- and water homeostasis. Notably, NiPKO mice displayed a
mild loss of sodium in the urine, and this phenotype was exacerbated in aged NiPKO mice
upon dietary sodium restriction. Aging is associated with a reduced ability to retain sodium
during salt depletion in humans [23], and with reduced renal PGC-1α levels in mice [24].
Thus, our study provides a potential link between reduced PGC-1α levels and the reduced
capacity to reabsorb sodium with age. While the underlying mechanism(s) needs to be eluci-
dated, we can demonstrate that inactivation of PGC-1α in kidney leads to decreased protein
levels of the sodium transporters NKCC2 and NCCT in kidney during low-salt diet feeding.
Even though the phosphorylation status of these two proteins remains unchanged, reduced lev-
els of the two important sodium channels during LSD-feeding could explain the urinary loss of
sodium with ablation of renal PGC-1α. However, without a more detailed segmental study, it is
unclear how PGC-1α is involved in the function of different parts of the nephron. A rudimen-
tary expression analysis using microdissected nephron segments indicates a relatively high
expression of PGC-1α in different parts of the tubulus, at least compared to transcript levels in
the glomerulus (S6 Fig). Intriguingly, a gradient towards increasing expression of PGC-1α in
the distal direction of the tubulus is observed, which could be linked to the salt-losing pheno-
type in the knockout mice.
The importance of renal PGC-1α for the transcriptional regulation of mitochondrial and
metabolic processes in kidney is in agreement with the effect of PGC-1α in other organs, such
as brown adipose tissue, skeletal muscle and heart [25]. Importantly, the similarities in tran-
scriptional profiles between these tissues could result not only from high basal expression of
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PGC-1α, but could also be due to the expression of the same TF partners of PGC-1α relevant
for mitochondrial transcription, such as nuclear respiratory factor 1 (NRF1), mitochondrial
transcription factor A (TFAM) and ERRα. Indeed, renal ERRα levels equal those of brown adi-
pose tissue and heart and exceed the levels in skeletal muscle [26,27]. Based on motif activity
response analysis of our gene expression data, we predicted a significant blunting of ERRα
transcriptional activity in our NiPKO mice. ERRα is an established partner of PGC-1α in the
regulation of mitochondrial gene transcription [16], and reduced activity ERRα correlates with
the impaired transcription of mitochondrial genes when PGC-1α is ablated in kidney. We also
predicted a significant reduction of KLF4 transcriptional activity in kidney of NiPKO mice.
KLF4 was recently shown to be an essential component of the transcription of mitochondrial
genes via PGC-1α and ERRα in heart [17]. Thus, KLF4 could likewise be a novel regulator of
mitochondrial gene transcription working together with PGC-1α in the kidney. Furthermore,
in our analysis, nuclear receptor 5A1 (NR5A1) and zinc finger protein 143 (ZNF143) were pre-
dicted to have a reduced transcriptional activity in NiPKOmice, and these TFs have been either
shown or at least predicted to be transcriptional partners of PGC-1α [28,29]. Interestingly,
ISMARA analysis implies both NR5A1 and ZNF143 to regulate mitochondrial gene transcrip-
tion in our dataset (data not shown). However, further studies are needed to elucidate the
potential role of these TFs as transcriptional partners of PGC-1α-mediated mitochondrial gene
transcription in kidney.
Mitochondrial dysfunction and decreased ATP production are associated with reduced
renal function and impaired transtubular transport [4,5]. Despite the inactivation of PGC-1α
in kidney and the reduction in mitochondrial transcription, NiPKO mice displayed a largely
normal renal phenotype. It is important to note that the effect of PGC-1α inactivation on mito-
chondrial protein content in our study was moderate, which in turn could explain the mild
phenotype. One likely explanation for this could be that the related family member PGC-1β
could compensate for the loss of PGC-1α in NiPKO mice, especially since redundancy between
PGC-1α and PGC-1β on mitochondrial gene transcription has been previously shown in skele-
tal muscle [30]. Another explanation for this observation would be that the role of PGC-1α in
kidney is more prominent during states of increased metabolic stress, as we demonstrated in
the context of HFD feeding, but also in other renal disease states. Indeed, several etiologically
distinct renal disorders, such as diabetic nephropathy, ischemia/reperfusion injury and sepsis
are associated with reduced mitochondrial function [19,20,21,22] and reduced levels or activity
of PGC-1α in the kidney [22,31,32]. The link between PGC-1α and renal disease was recently
explored in two studies by Tran et al. [22,33], where the authors show that deletion of PGC-1α
specifically in the renal proximal tubules leads to a worsened renal phenotype in mice during
acute ischemic kidney injury [22] while overexpression of PGC-1α helps to protect against
damage [33]. Recent studies have also shown that treatment with the SIRT1-activator SRT1720
[20] or calorie restriction [31], which are linked to increased PGC-1α activation, improves the
renal mitochondrial phenotype and reduces ischemia/reperfusion injury in mice. Moreover,
overexpression of PGC-1α in cultured proximal tubule cells protects against both TNFα- [22]
and aldosterone-induced [32] mitochondrial dysfunction. Hence, while our current study dem-
onstrates a minor role for PGC-1α in basal salt- and water handling and blood pressure regula-
tion in kidney, increased PGC-1α activity could be a valid therapeutic strategy to ameliorate
renal mitochondrial dysfunction in a broad spectrum of renal disorders. In particular, our data
highlight the importance of PGC-1α in the kidney during metabolic stress, since we found that
absence of PGC-1α leads to enhanced deposition of triglycerides in kidney of HFD-fed mice.
Transcriptional analysis showed that upon HFD feeding, induction of PPARα and several
PPARα-targets involved in fatty acid metabolism were significantly blunted in the kidney of
NiPKO mice. Indeed, PPARα is a well-known transcriptional partner of PGC-1α for the
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regulation of lipid metabolism [34]. Importantly, ablation of PPARα in mice leads to an
increased susceptibility to diabetic nephropathy [35] and exacerbated free fatty acid-induced
injury in the kidney [36]. Moreover, increased PPARα-activity in obese rodents protects
against renal lipotoxicity [37,38] and has been associated with increased levels of PGC-1α in
kidney [39]. Obesity and HFD feeding lead to ectopic deposition of triglyceride in the kidney
[38,40]. Both PGC-1α and PPARα have been described as inhibitors of NF-κB activity [18,41].
Thus, both PGC-1α and PPARα could be instrumental in attenuating an inflammatory reac-
tion triggered by pathological accumulation of lipids in the kidney as in other tissues [42]. Our
findings highlight an important link between reduced renal PGC-1α levels and deregulated
lipid metabolism in kidney. Further studies are now needed to address the potential protective
effect of increased PGC-1α activity in diseases associated with defective renal lipid metabolism
and lipotoxicity.
In summary, we found that PGC-1α plays a marked role in the transcriptional regulation of
several interconnected mitochondrial gene programs in the kidney, such as oxidative phos-
phorylation, TCA cycle and fatty acid metabolism. While inactivation of tubular PGC-1α
resulted in a minor increase in urinary sodium excretion that was exacerbated by age and high
fat diet feeding, there was no further impairment in salt- and water homeostasis or blood pres-
sure regulation in NiPKO mice. Importantly, our data demonstrate a crucial role for PGC-1α
in the regulation of renal lipid metabolism during metabolic stress, leading to elevated renal
steatosis in the absence of functional PGC-1α. While our findings point towards a minor role
of PGC-1α in basal renal physiology, we thus hypothesize that activation of PGC-1α in the
context of renal disorders could be a valid therapeutic strategy to ameliorate renal mitochon-
drial dysfunction in a broad spectrum of renal disorders.
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